See Monoclonal Antibody.
Glossary
MAb
02.27.12
-
Breaking News | Industry News
Lilly’s Antibody Treatment Gets EUA for Post-Exposure COVID Prevention
Phase 3 study shows bamlanivimab 4200 mg reduced the risk of contracting symptomatic COVID-19 by up to 80 percent in nursing home residents.
-
Breaking News | Industry News
U.S. Govt. Purchases Additional Doses of Lilly's Antibody Therapies for COVID
Will supply 388,000 doses of etesevimab to complement doses of bamlanivimab previously purchased, with approximately 200,000 doses expected to ship 3Q21.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Repligen and Navigo Launch Antibody Technology Platform
Introduce industry-first protein A ligand for purification of pH sensitive antibodies.
-
Breaking News | Financial Reports
Pfizer's 2Q Revenues Up 92%
COVID-19 vaccine BNT162b2 contributes $7.8 billion in sales and alliance revenues.
-
Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Abzena, BioXpress Therapeutics Enter Biosimilar Tie-up
Partnership to support the development and manufacture of biosimilars for global customers.
